株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

解剖病理学の世界市場 - 2024年までの予測:計器 (組織処理装置、ミクロトーム)、消耗品 (抗体)

Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab): Global Forecast to 2024

発行 MarketsandMarkets 商品コード 479764
出版日 ページ情報 英文 195 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
解剖病理学の世界市場 - 2024年までの予測:計器 (組織処理装置、ミクロトーム)、消耗品 (抗体) Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtomes), Consumables (Antibodies), Histopathology), Application (Disease Diagnosis (Cancer (Gastrointestinal)), End User (Hospital, Lab): Global Forecast to 2024
出版日: 2019年10月30日 ページ情報: 英文 195 Pages
概要

解剖病理学市場は、2019年の330億米ドルから、2024年までに444億米ドルまで拡大すると見られています。市場は、2019年~2024年のCAGR (複合年間成長率) で、6.1%の成長が予測されています。

当レポートでは、世界の解剖病理学市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

479764_FIGURE 26_ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, BY INSTRUMENT AND CONSUMABLE PROVIDER, 2018

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 解剖病理学:市場概要
  • 北米 - 解剖病理学市場:製品・サービス別
  • 解剖病理学市場の地域別スナップショット

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 機会
    • 課題
    • 動向

第6章 解剖病理学の世界市場:製品・サービス別

  • イントロダクション
  • サービス
  • 消耗品
  • 計器

第7章 解剖病理学の世界市場:用途別

  • イントロダクション
  • 疾患診断
  • 医学研究

第8章 解剖病理学の世界市場:エンドユーザー別

  • イントロダクション
  • 病院検査室
  • 臨床検査室
  • その他

第9章 解剖病理学の世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第10章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合シナリオ
  • 競合リーダーシップマッピング

第11章 企業プロファイル

  • F. HOFFMAN-LA ROCHE LTD.
  • DANAHER
  • THERMO FISHER SCIENTIFIC
  • ABCAM PLC.
  • HOLOGIC, INC.
  • AGILENT TECHNOLOGIES
  • BECTON, DICKINSON AND COMPANY
  • SAKURA FINETEK USA INC.
  • MERCK KGAA
  • BIO SB
  • BIOGENEX
  • MILESTONE MEDICAL
  • HISTO-LINE LABORATORIES
  • DIAPATH S.P.A.
  • SLEE MEDICAL GMBH
  • AMOS SCIENTIFIC PTY LTD
  • MEDITE GMBH
  • CELL SIGNALING TECHNOLOGY
  • CELLPATH LTD.
  • JINHUA YIDI MEDICAL APPLIANCE CO. LTD

第12章 付録

図表

LIST OF TABLES

  • TABLE 1: GLOBAL CANCER INCIDENCE, 2018 VS. 2025
  • TABLE 2: GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008-2016
  • TABLE 3: NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
  • TABLE 4: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 5: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6: HISTOPATHOLOGY SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: CYTOPATHOLOGY SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 9: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 10: PRIMARY ANTIBODIES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: SECONDARY ANTIBODIES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 13: STAINS & SOLVENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: FIXATIVES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: OTHER KITS & REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: PROBES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: OTHER CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 19: SLIDE STAINING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: TISSUE PROCESSING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: CELL PROCESSORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: MICROTOMES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: EMBEDDING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: COVERSLIPPERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 25: OTHER INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 27: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2017-2024 (USD MILLION)
  • TABLE 28: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 29: BREAST CANCER INCIDENCE, BY REGION, 2018 VS. 2025
  • TABLE 30: ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31: STOMACH CANCER INCIDENCE, BY REGION, 2018 VS. 2025
  • TABLE 32: ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: LUNG CANCER INCIDENCE, BY REGION, 2018 VS. 2025
  • TABLE 34: ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: PROSTATE CANCER INCIDENCE, BY REGION, 2018 VS. 2025
  • TABLE 36: ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 38: ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 39: ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 41: ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 42: ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 44: ANATOMIC PATHOLOGY MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 45: NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46: NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 47: NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 48: NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 49: NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 50: NORTH AMERICA: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 51: NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 53: NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 54: NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 56: US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 57: US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 58: US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: US: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61: US: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 62: US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 63: US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 64: US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 65: US: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 66: CANADA: KEY MACROINDICATORS
  • TABLE 67: CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 68: CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 70: CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 71: CANADA: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 72: CANADA: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 74: CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 75: CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 76: CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 77: EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 78: EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 79: EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 80: EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 81: EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 82: EUROPE: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 83: EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 85: EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86: EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 87: EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 88: INCIDENCE OF CANCER, BY TYPE, 2018 VS. 2025
  • TABLE 89: GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 90: GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91: GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92: GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 93: GERMANY: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 94: GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95: GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 96: GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 99: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
  • TABLE 100: FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 101: FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 102: FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 103: FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: FRANCE: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105: FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 106: FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 107: FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 108: FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 109: FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 110: UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 111: UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 112: UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 113: UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 114: UK: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: UK: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 116: UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 117: UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 118: UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 119: UK: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 120: INCIDENCE OF CANCER, BY TYPE, 2018 VS. 2025
  • TABLE 121: ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 122: ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 123: ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 124: ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 125: ITALY: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 126: ITALY: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127: ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 128: ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 129: ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 130: ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 131: SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 132: SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 133: SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 134: SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 135: SPAIN: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 136: SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 137: SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 138: SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 139: SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 140: SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 141: ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 142: ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 143: ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 144: ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 145: ROE: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 146: ROE: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 147: ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 148: ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 149: ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 150: ROE: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 151: ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 152: ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 153: ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 154: ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 155: ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 156: ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE 2017-2024 (USD MILLION)
  • TABLE 157: ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE 2017-2024 (USD MILLION)
  • TABLE 158: ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 159: ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 160: ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 161: ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 162: JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 163: JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 164: JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 165: JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 166: JAPAN: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 167: JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 168: JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 169: JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 170: JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 171: JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 172: CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 173: CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 174: CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 175: CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 176: CHINA: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 177: CHINA: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 178: CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 179: CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 180: CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 181: CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 182: INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 183: INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 184: INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 185: INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 186: INDIA: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 187: INDIA: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 188: INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 189: INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 190: INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 191: INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 192: ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 193: ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 194: ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 195: ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 196: ROAPAC: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 197: ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 198: ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 199: ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 200: ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 201: ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 202: ROW: ANATOMIC PATHOLOGY MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 203: ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 204: ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 205: ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 206: ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 207: ROW: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 208: ROW: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 209: ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 210: ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 211: ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 212: ROW: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 213: LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 214: LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 215: LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 216: LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 217: LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 218: LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 219: LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 220: LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 221: LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 222: LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 223: MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 224: MIDDLE EAST & AFRICA : ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 225: MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 226: MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 227: MIDDLE EAST & AFRICA: ANTIBODIES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 228: MIDDLE EAST & AFRICA: KITS & REAGENTS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 229: MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 230: MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 231: MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 232: MIDDLE EAST & AFRICA: ANATOMIC PATHOLOGY MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: ANATOMIC PATHOLOGY MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: ANATOMIC PATHOLOGY MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 11: ANATOMIC PATHOLOGY MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 12: ANATOMIC PATHOLOGY MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 13: HIGH INCIDENCE OF CANCER & OTHER TARGET DISEASES TO DRIVE MARKET GROWTH
  • FIGURE 14: SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN ANATOMIC PATHOLOGY MARKET IN 2018
  • FIGURE 15: COUNTRIES IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 16: ANATOMIC PATHOLOGY MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
  • FIGURE 17: SERVICES TO CONTINUE TO DOMINATE THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: DISEASE DIAGNOSTICS APPLICATIONS TO CONTINUE TO DOMINATE THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: HOSPITAL LABORATORIES TO DOMINATE THE ANATOMIC PATHOLOGY MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA WILL CONTINUE TO DOMINATE THE ANATOMIC PATHOLOGY MARKET IN 2024
  • FIGURE 21: NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT
  • FIGURE 22: US: CANCER STATISTICS
  • FIGURE 23: CANADA: CANCER STATISTICS
  • FIGURE 24: KEY DEVELOPMENTS IN THE ANATOMIC PATHOLOGY MARKET BETWEEN 2016 AND 2019
  • FIGURE 25: MARKET EVOLUTION FRAMEWORK
  • FIGURE 26: ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, BY INSTRUMENT AND CONSUMABLE PROVIDER, 2018
  • FIGURE 27: MNM DIVE-VENDOR COMPARISON MATRIX: ANATOMIC PATHOLOGY MARKET
  • FIGURE 28: COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE (2018)
  • FIGURE 29: COMPANY SNAPSHOT: DANAHER (2018)
  • FIGURE 30: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2018)
  • FIGURE 31: COMPANY SNAPSHOT: ABCAM PLC. (2018)
  • FIGURE 32: COMPANY SNAPSHOT: HOLOGIC, INC. (2018)
  • FIGURE 33: COMPANY SNAPSHOT: AGILENT TECHNOLOGIES (2018)
  • FIGURE 34: COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2018)
  • FIGURE 35: COMPANY SNAPSHOT: MERCK KGAA (LIFE SCIENCES SEGMENT) (2018)
目次
Product Code: MD 5104

"High incidence of cancer & other target diseases, availability of reimbursement, and the growing focus on personalized medicine are driving the overall growth of the anatomic pathology market"

The anatomic pathology market is projected to reach a value of USD 44.4 billion by 2024 from USD 33.0 billion in 2019, at a CAGR of 6.1% during the forecast period. The growth in this market is attributed to the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper market growth to a certain extent in the coming years.

"Disease diagnosis segment accounted for the larger share of the anatomic pathology market, by application, in 2018"

Based on application, the anatomic pathology market is segmented into disease diagnosis and medical research. In 2018, the disease diagnosis segment accounted for the larger market share, due to the rapid growth in the geriatric population and the increasing incidence of cancer and other chronic diseases.

"Hospital laboratories to register the highest growth in the anatomic pathology market during the forecast period"

Based on end user, the anatomic pathology market is segmented into clinical laboratories, hospital laboratories, and other end users. The hospital laboratories segment accounted for the largest market share in 2018 and is projected to register the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing number of patient visits to hospitals, growing number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early disease diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

"North America will continue to dominate the anatomic pathology market during the forecast period"

Geographically, the anatomic pathology market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America accounted for the largest market share, followed by Europe. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 36%, Tier 2 - 45%, and Tier 3 - 19%
  • By Designation: C-level - 33%, D-level - 40%, and Others - 27%
  • By Region: North America - 36%, Europe - 28%, Asia Pacific - 19%, and the Rest of the World - 17%

List of Companies Profiled in the Report:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Danaher Corporation (US)
  • Thermo Fisher Scientific (US)
  • Hologic, Inc. (US)
  • Agilent Technologies (US)
  • Becton, Dickinson and Company (US)
  • Sakura Finetek (Japan)
  • Merck KGaA (Germany)
  • Bio SB (US)
  • Diapath S.p.A. (Italy)
  • BioGenex Laboratories (US)
  • Abcam (US)
  • Milestone Medical (Italy)
  • SLEE medical (Germany)
  • Histo-Line Laboratories (Italy)
  • Amos Scientific (Australia)
  • Jinhua YIDI Medical Appliance Co. Ltd. (China)
  • MEDITE GmbH (Germany)
  • Cell Signaling Technology (US)
  • CellPath (UK)

Research Coverage:

This report provides a detailed picture of the global anatomic pathology market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall anatomic pathology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 SECONDARY DATA
    • 2.2.1 SECONDARY SOURCES
  • 2.3 PRIMARY DATA
  • 2.4 MARKET SIZE ESTIMATION
    • 2.4.1 BOTTOM-UP APPROACH
      • 2.4.1.1 Bottom-up approach for the instruments and consumables market
    • 2.4.2 TOP-DOWN APPROACH
      • 2.4.2.1 SERVICES MARKET ESTIMATION BASED ON NUMBER OF TESTS
      • 2.4.2.2 SERVICES MARKET ESTIMATION BASED ON PROCEDURES
    • 2.4.3 GROWTH FORECAST
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

  • 3.1 INTRODUCTION

4 PREMIUM INSIGHTS

  • 4.1 ANATOMIC PATHOLOGY: MARKET OVERVIEW
  • 4.2 NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE ANATOMIC PATHOLOGY MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High incidence of cancer and other target diseases
      • 5.2.1.2 Recommendations for cancer screening
      • 5.2.1.3 Availability of reimbursement
      • 5.2.1.4 Growing focus on personalized medicine
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Emerging economies
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Availability of refurbished products
      • 5.2.3.2 Lack of skilled professionals
      • 5.2.3.3 Product failures and recalls
    • 5.2.4 TRENDS
      • 5.2.4.1 Reagent rental agreements

6 ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 SERVICES
    • 6.2.1 HISTOPATHOLOGY
      • 6.2.1.1 The majority of cancers are diagnosed via histopathology-a key factor driving market growth
    • 6.2.2 CYTOPATHOLOGY
      • 6.2.2.1 Government focus on cervical cancer screening has boosted the growth of the cytopathology services market
  • 6.3 CONSUMABLES
    • 6.3.1 ANTIBODIES
      • 6.3.1.1 Primary antibodies
        • 6.3.1.1.1 North America dominates the primary antibodies market
      • 6.3.1.2 Secondary antibodies
        • 6.3.1.2.1 Asia Pacific will show the highest growth in the market for secondary antibodies
    • 6.3.2 KITS & REAGENTS
      • 6.3.2.1 Stains & solvents
        • 6.3.2.1.1 North America accounted for highest share in this market
      • 6.3.2.2 Fixatives
        • 6.3.2.2.1 North America accounts for the largest share of the fixatives market
      • 6.3.2.3 Other kits & reagents
    • 6.3.3 PROBES
      • 6.3.3.1 APAC is expected to show the highest growth in the probes market
    • 6.3.4 OTHER CONSUMABLES
  • 6.4 INSTRUMENTS
    • 6.4.1 SLIDE STAINING SYSTEMS
      • 6.4.1.1 Availability of automated systems will drive market growth during the forecast period
    • 6.4.2 TISSUE PROCESSING SYSTEMS
      • 6.4.2.1 Rising adoption of automation is a key trend in the tissue processing systems market
    • 6.4.3 CELL PROCESSORS
      • 6.4.3.1 Cell processors are used to remove unwanted matter in samples-making them important instruments in the market
    • 6.4.4 MICROTOMES
      • 6.4.4.1 North America accounts for the largest share of the microtomes market
    • 6.4.5 EMBEDDING SYSTEMS
      • 6.4.5.1 Asia Pacific is expected to register the highest growth during the forecast period
    • 6.4.6 COVERSLIPPERS
      • 6.4.6.1 Coverslippers are widely used instruments in research alongside staining systems
    • 6.4.7 OTHER INSTRUMENTS

7 ANATOMIC PATHOLOGY MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 DISEASE DIAGNOSTICS
    • 7.2.1 CANCER
      • 7.2.1.1 Breast cancer
        • 7.2.1.1.1 Breast cancer holds the highest mortality rate among cancers in North America
      • 7.2.1.2 Gastrointestinal cancer
        • 7.2.1.2.1 North America accounts for the largest share of the anatomic pathology market for gastrointestinal cancer
      • 7.2.1.3 Lung cancer
        • 7.2.1.3.1 Lung cancer is the most common cancer in the world
      • 7.2.1.4 Prostate cancer
        • 7.2.1.4.1 Prostate is the third-leading cause of death by cancer in North America
      • 7.2.1.5 Other cancers
    • 7.2.2 OTHER DISEASES
  • 7.3 MEDICAL RESEARCH
    • 7.3.1 GROWING RESEARCH ACTIVITIES WILL DRIVE THE ADOPTION OF ANATOMIC PATHOLOGY PRODUCTS IN THIS APPLICATION SEGMENT

8 ANATOMIC PATHOLOGY MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITAL LABORATORIES
    • 8.2.1 HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
  • 8.3 CLINICAL LABORATORIES
    • 8.3.1 INCREASING OUTPATIENT SURGERIES TO DRIVE THE GROWTH OF THIS SEGMENT
  • 8.4 OTHER END USERS

9 ANATOMIC PATHOLOGY MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 The US dominates the global anatomic pathology market
    • 9.2.2 CANADA
      • 9.2.2.1 High burden of cancer to support market growth
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Availability of reimbursement for colorectal cancer screening to support market growth
    • 9.3.2 FRANCE
      • 9.3.2.1 Government funding for cancer diagnosis & prevention to support market growth
    • 9.3.3 UK
      • 9.3.3.1 Government initiatives to drive market growth in the UK
    • 9.3.4 ITALY
      • 9.3.4.1 High incidence of cancer and increasing per capita healthcare spending to support market growth in Italy
    • 9.3.5 SPAIN
      • 9.3.5.1 High incidence of chronic diseases to drive the Spanish market
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 Presence of a well-developed healthcare system to support market growth in Japan
    • 9.4.2 CHINA
      • 9.4.2.1 Rising healthcare expenditure to drive the market growth
    • 9.4.3 INDIA
      • 9.4.3.1 Growing healthcare sector in the country to drive market growth
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 LATIN AMERICA
      • 9.5.1.1 Cancer screening programs to support market growth
    • 9.5.2 MIDDLE EAST & AFRICA
      • 9.5.2.1 Increasing incidence of cancer in Africa to support market growth

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS, 2018
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 AGREEMENTS & PARTNERSHIPS (2016-2019)
    • 10.3.2 EXPANSIONS (2016-2019)
    • 10.3.3 PRODUCT LAUNCHES & APPROVALS (2016-2019)
    • 10.3.4 ACQUISITIONS (2016-2019)
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 10.4.1 VENDOR INCLUSION CRITERIA
    • 10.4.2 VISIONARY LEADERS
    • 10.4.3 INNOVATORS
    • 10.4.4 DYNAMIC DIFFERENTIATORS
    • 10.4.5 EMERGING COMPANIES

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 11.1 F. HOFFMAN-LA ROCHE LTD.
  • 11.2 DANAHER
  • 11.3 THERMO FISHER SCIENTIFIC
  • 11.4 ABCAM PLC.
  • 11.5 HOLOGIC, INC.
  • 11.6 AGILENT TECHNOLOGIES
  • 11.7 BECTON, DICKINSON AND COMPANY
  • 11.8 SAKURA FINETEK USA INC.
  • 11.9 MERCK KGAA
  • 11.10 BIO SB
  • 11.11 BIOGENEX
  • 11.12 MILESTONE MEDICAL
  • 11.13 HISTO-LINE LABORATORIES
  • 11.14 DIAPATH S.P.A.
  • 11.15 SLEE MEDICAL GMBH
  • 11.16 AMOS SCIENTIFIC PTY LTD
  • 11.17 MEDITE GMBH
  • 11.18 CELL SIGNALING TECHNOLOGY
  • 11.19 CELLPATH LTD.
  • 11.20 JINHUA YIDI MEDICAL APPLIANCE CO. LTD

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS
Back to Top